A significant discovery in cancer research is emerging with the use of nanobodies to re-engage mutated p53. This vital malignant protector protein is frequently disabled in several kinds of tumors, leading uncontrolled https://bookmarkingquest.com/story21869454/mini-antibodies-restore-the-p53-protein-a-new-pathway-for-tumor-management